unknown
Stage
About
Biomagnetik develops quantum-sensor-based magnetocardiography (MCG) hardware and software to non-invasively measure cardiac ion currents and enable diagnostic scores and assays for cardiology. The company combines quantum sensors and AI to build a semi-open clinical platform for cardiac diagnostics and precision medicine in collaboration with institutions such as Charité Berlin.
Explore Biomagnetik's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.